You are here

  • Home
  • Archive
  • Volume 99, Issue Suppl 3
  • GW24-e2397 Rosuvastatin could modulate insulin signalling and inhibit atherosclerosis beyond its plasma cholesterol-lowering effect in insulin-resistant mice

Alerts

Article menu
Download PDFPDF
Basic and Translational Medicine
Basic research of cardiovascular disease
GW24-e2397 Rosuvastatin could modulate insulin signalling and inhibit atherosclerosis beyond its plasma cholesterol-lowering effect in insulin-resistant mice
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address